BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21515903)

  • 21. Neuroimaging findings in DYT1 dystonia and the pathophysiological implication: A systematic review.
    Taiwo FT; Adebayo PB
    Brain Behav; 2023 Jun; 13(6):e3023. PubMed ID: 37165749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New THAP1 mutation and role of putative modifier in TOR1A.
    Piovesana LG; Torres FR; Azevedo PC; Amaral TP; Lopes-Cendes I; D'Abreu A
    Acta Neurol Scand; 2017 Feb; 135(2):183-188. PubMed ID: 26940431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice.
    Uluğ AM; Vo A; Argyelan M; Tanabe L; Schiffer WK; Dewey S; Dauer WT; Eidelberg D
    Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6638-43. PubMed ID: 21464304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathology and morphometry of dentate nucleus neurons in DYT1 brains: Cerebellar abnormalities in isolated dystonia.
    Iacono D; Peng H; Rabin ML; Kurlan R
    J Neuropathol Exp Neurol; 2023 Jul; 82(8):695-706. PubMed ID: 37352388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers.
    Edwards MJ; Huang YZ; Mir P; Rothwell JC; Bhatia KP
    Mov Disord; 2006 Dec; 21(12):2181-6. PubMed ID: 17078060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-specific Dyt1 ∆GAG knock-in to basal ganglia and cerebellum reveal differential effects on motor behavior and sensorimotor network function.
    Wilkes BJ; Adury RZ; Berryman D; Concepcion LR; Liu Y; Yokoi F; Maugee C; Li Y; Vaillancourt DE
    Exp Neurol; 2023 Sep; 367():114471. PubMed ID: 37321386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation.
    Edwards MJ; Huang YZ; Wood NW; Rothwell JC; Bhatia KP
    Brain; 2003 Sep; 126(Pt 9):2074-80. PubMed ID: 12821514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pallidal deep brain stimulation for DYT6 dystonia.
    Panov F; Tagliati M; Ozelius LJ; Fuchs T; Gologorsky Y; Cheung T; Avshalumov M; Bressman SB; Saunders-Pullman R; Weisz D; Alterman RL
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):182-7. PubMed ID: 21949105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial Discrimination Threshold Abnormalities are not Detected in a Pilot Study of DYT6 Dystonia Mutation Carriers.
    Deik AF; O'Riordan S; Luciano MS; Shanker VL; Raymond D; Bressman SB; Saunders-Pullman R
    Tremor Other Hyperkinet Mov (N Y); 2012; 2():. PubMed ID: 23439738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New approaches in dystonia (clinical features, genetic issues and pathophysiology].
    Vidailhet M; Grabli D
    Bull Acad Natl Med; 2011; 195(4-5):921-34; discussion 934. PubMed ID: 22375360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation.
    Mure H; Tang CC; Argyelan M; Ghilardi MF; Kaplitt MG; Dhawan V; Eidelberg D
    J Neurosci; 2012 Feb; 32(8):2804-13. PubMed ID: 22357863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcellular distribution of THAP1 and alterations in the microstructure of brain white matter in DYT6 dystonia.
    Cheng FB; Wan XH; Feng JC; Ma LY; Hou B; Feng F; Wang L; Yang YM
    Parkinsonism Relat Disord; 2012 Sep; 18(8):978-82. PubMed ID: 22652465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obsessive-compulsive disorder is not a clinical manifestation of the DYT1 dystonia gene.
    Heiman GA; Ottman R; Saunders-Pullman RJ; Ozelius LJ; Risch NJ; Bressman SB
    Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):361-4. PubMed ID: 17066475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THAP1/DYT6 sequence variants in non-DYT1 early-onset primary dystonia in China and their effects on RNA expression.
    Cheng FB; Ozelius LJ; Wan XH; Feng JC; Ma LY; Yang YM; Wang L
    J Neurol; 2012 Feb; 259(2):342-7. PubMed ID: 21800139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites.
    Saunders-Pullman R; Fuchs T; San Luciano M; Raymond D; Brashear A; Ortega R; Deik A; Ozelius LJ; Bressman SB
    Mov Disord; 2014 May; 29(6):812-8. PubMed ID: 24500857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
    Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
    Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging.
    Niethammer M; Carbon M; Argyelan M; Eidelberg D
    Neurobiol Dis; 2011 May; 42(2):202-9. PubMed ID: 20965251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for THAP1 Mutations in Polish Patients with Dystonia Shows Known and Novel Substitutions.
    Golanska E; Gajos A; Sieruta M; Szybka M; Rudzinska M; Ochudlo S; Kmiec T; Liberski PP; Bogucki A
    PLoS One; 2015; 10(6):e0129656. PubMed ID: 26087139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disordered network structure and function in dystonia: pathological connectivity vs. adaptive responses.
    Vo A; Nguyen N; Fujita K; Schindlbeck KA; Rommal A; Bressman SB; Niethammer M; Eidelberg D
    Cereb Cortex; 2023 May; 33(11):6943-6958. PubMed ID: 36749014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited dystonias: clinical features and molecular pathways.
    Weisheit CE; Pappas SS; Dauer WT
    Handb Clin Neurol; 2018; 147():241-254. PubMed ID: 29325615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.